2MPS image
Entry Detail
PDB ID:
2MPS
Keywords:
Title:
Structure of complex of MDM2(3-109) and P73 TAD(10-25)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2014-06-02
Release Date:
2015-06-03
Method Details:
Experimental Method:
Conformers Calculated:
100
Conformers Submitted:
20
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:E3 ubiquitin-protein ligase Mdm2
Chain IDs:A
Chain Length:107
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Tumor protein p73
Chain IDs:B
Chain Length:16
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition
Cell Cycle 14 533 543 (2015)
PMID: 25591003 DOI: 10.1080/15384101.2014.998056

Abstact

The p53, p63, and p73 proteins belong to the p53 family of transcription factors, which play key roles in tumor suppression. Although the transactivation domains (TADs) of the p53 family are intrinsically disordered, these domains are commonly involved in the regulatory interactions with mouse double minute 2 (MDM2). In this study, we determined the solution structure of the p73TAD peptide in complex with MDM2 using NMR spectroscopy and biophysically characterized the interactions between the p53 family TAD peptides and MDM2. In combination with mutagenesis data, the complex structures revealed remarkably close mimicry of the MDM2 recognition mechanism among the p53 family TADs. Upon binding with MDM2, the intrinsically disordered p73TAD and p63TAD peptides adopt an amphipathic α-helical conformation, which is similar to the conformation of p53TAD, although the α-helical content induced by MDM2 binding varies. With isothermal titration calorimetry (ITC) and circular dichroism (CD) data, our biophysical characterization showed that p73TAD resembles p53TAD more closely than p63TAD in terms of helical stability, MDM2 binding affinity, and phosphorylation effects on MDM2 binding. Therefore, our structural information may be useful in establishing alternative anticancer strategies that exploit the activation of the p73 pathway against human tumors bearing p53 mutations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures